Skip to content
buyWeak

Laith L Yaldoo bought $50k of ZIVO

director, owner at Zivo Bioscience, Inc.. 3,488 shares at an average of $14.33, traded Jun 13, 2025, filed Jun 16, 2025.

Conviction score
25
Value
$50k
3,488 shares
Holdings after
558,114
+1% from before
From 52-week low
+17%
low $12.00, close $13.99
From 52-week high
-37%
high $22.10, as of Jun 13, 2025

Score components

  • Role
    Director
    +15
  • Trade size
    $50k at market
    +7
  • Relative to holdings
    Under 1% of holdings (0.6%)
    -5
  • Price context
    37% below the 52-week high
    +8
  • Cluster
    No other insider buying within 14 days
    0
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (1 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m +2.2%, 3m +2.4%, 6m -30.8%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

ZIVOOct 9, 2026 · close 5.30
Since filing Jun 16, 2025: -59.2%SPY +31.3% · excess -90.6%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001654954-25-007028, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Jun 13, 2025POpen-market purchase
Common Stockindirect: By HEP Investments LLC
+3,488$14.33$50k558,114Jun 16, 2025
Jun 13, 2025POpen-market purchase
Warrant for Common Stockderivativeindirect: By HEP Investments LLC
+348$14.33$4,987348Jun 16, 2025

Related signals

Other insiders at Zivo Bioscience, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
43Moderate
ZIVObuy
Zivo Bioscience, Inc.
Mark E Strome
owner
$200k
100,000 shares
+21%
23Weak
ZIVObuy
Zivo Bioscience, Inc.
Laith L Yaldoo
director, owner
$15k
1,543 shares
+0%
35Weak
ZIVObuy 2
Zivo Bioscience, Inc.
Mark E Strome
owner
$195k
20,000 shares
+4%
31Weak
ZIVObuy 2
Zivo Bioscience, Inc.
Laith L Yaldoo
director, owner
$25k
2,434 shares
+0%
48Moderate
ZIVObuy 4
Zivo Bioscience, Inc.
Alison A Cornell
director
$100k
11,709 shares
+4%
68Notable
ZIVObuy 4
Zivo Bioscience, Inc.
John Bernard Payne
President and CEO
$100k
11,709 shares
+148%
33Weak
ZIVObuy 4
Zivo Bioscience, Inc.
Christopher D. Maggiore
director, owner
$15k
1,766 shares
+0%
38Weak
ZIVObuy 4
Zivo Bioscience, Inc.
Laith L Yaldoo
director, owner
$15k
1,766 shares
+0%
23Weak
ZIVObuy
Zivo Bioscience, Inc.
Laith L Yaldoo
director, owner
$25k
2,777 shares
+0%
43Moderate
ZIVObuy 3
Zivo Bioscience, Inc.
Mark E Strome
owner
$250k
20,259 shares
+5%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.